﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Immunopathologia Persa</JournalTitle>
      <Issn>2423-8015</Issn>
      <Volume>9</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>06</Month>
        <DAY>17</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Potential factors related to post-COVID-19 persistent symptoms; Khorshid COVID cohort study</ArticleTitle>
    <FirstPage>22223</FirstPage>
    <LastPage>22223</LastPage>
    <ELocationID EIdType="doi">10.34172/ipp.2022.22223</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ramin</FirstName>
        <LastName>Sami</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-7521-4631</Identifier>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Khani Khoozani</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-8334-6127</Identifier>
      </Author>
      <Author>
        <FirstName>Marjan</FirstName>
        <LastName>Mansourian</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-7217-0282</Identifier>
      </Author>
      <Author>
        <FirstName>Zohre</FirstName>
        <LastName>Naderi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0554-6067</Identifier>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Karami</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-5829-1320</Identifier>
      </Author>
      <Author>
        <FirstName>Mina</FirstName>
        <LastName>Nickpour</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9628-4241</Identifier>
      </Author>
      <Author>
        <FirstName>Arash</FirstName>
        <LastName>Toghyani</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-2342-7982</Identifier>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Gharavinia</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8186-5158</Identifier>
      </Author>
      <Author>
        <FirstName>Nastaran Sadat</FirstName>
        <LastName>Hosseini</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-7705-7783</Identifier>
      </Author>
      <Author>
        <FirstName>Mehrnegar</FirstName>
        <LastName>Dehghan</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-6313-575X</Identifier>
      </Author>
      <Author>
        <FirstName>Midia</FirstName>
        <LastName>Babahajiani</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9308-1879</Identifier>
      </Author>
      <Author>
        <FirstName>Nafiseh</FirstName>
        <LastName>Shokri-Mashhadi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4967-4412</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/ipp.2022.22223</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>01</Month>
        <Day>01</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>02</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Recently, a high percentage of post-discharge patients have reported persistent symptoms after COVID-19 recovery. However, there is limited comprehensive information regarding nature’s symptoms and association with potential factors. Objectives: We aimed to assess the inpatients’ characteristics and the prevalence of COVID-19 symptoms at admission and four weeks after recovery to recognize the potential factors related to the persistent symptoms. Patients and Methods: We assessed the medical information of 262 severe and 546 non-severe COVID-19 inpatients at admission, and during the first and four weeks after post-discharge from the Khorshid COVID Cohort (KCC) study. Results: Cough, dyspnea, and fatigue were the most reported symptoms at admission, and continuously were declined over the time (all P&lt;0.01). However, the complaint of weight loss was increased during follow-up (P=0.01). Older age (P&lt;0.0001), male gender (P=0.02), administration of hydroxychloroquine (P=0.017), and the interval time from illness onset to visit hospital (P&lt;0.0001) augmented the remaining respiratory symptoms risk. Additionally, more length of hospital stay correlated to the lower risk of persistent constitutional symptoms (P&lt;0.05). Conclusion: This study points out the greater rehabilitation needs and management of persistent symptoms, in particular cough, dyspnea, fatigue and weight loss, and their related factors. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">COVID-19</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Post-discharge</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Follow up</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Persistent symptoms</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>